Pliant Therapeuticsinc Stock Market Value
| PLRX Stock | USD 12.13 0.04 0.33% |
| Symbol | Pliant |
Pliant TherapeuticsInc Price To Book Ratio
Is Pliant TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pliant TherapeuticsInc. If investors know Pliant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pliant TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.86) | Revenue Per Share 0.004 | Quarterly Revenue Growth (1.00) | Return On Assets (0.22) | Return On Equity (0.34) |
The market value of Pliant TherapeuticsInc is measured differently than its book value, which is the value of Pliant that is recorded on the company's balance sheet. Investors also form their own opinion of Pliant TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Pliant TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pliant TherapeuticsInc's market value can be influenced by many factors that don't directly affect Pliant TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pliant TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pliant TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pliant TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pliant TherapeuticsInc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pliant TherapeuticsInc's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pliant TherapeuticsInc.
| 03/04/2024 |
| 06/02/2024 |
If you would invest 0.00 in Pliant TherapeuticsInc on March 4, 2024 and sell it all today you would earn a total of 0.00 from holding Pliant TherapeuticsInc or generate 0.0% return on investment in Pliant TherapeuticsInc over 90 days. Pliant TherapeuticsInc is related to or competes with Relay TherapeuticsInc, Stoke Therapeutics, Black Diamond, Arvinas, 89bio, Madrigal Pharmaceuticals, and Arcellx. Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel the... More
Pliant TherapeuticsInc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pliant TherapeuticsInc's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pliant TherapeuticsInc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 14.13 | |||
| Value At Risk | (5.16) | |||
| Potential Upside | 4.66 |
Pliant TherapeuticsInc Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pliant TherapeuticsInc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pliant TherapeuticsInc's standard deviation. In reality, there are many statistical measures that can use Pliant TherapeuticsInc historical prices to predict the future Pliant TherapeuticsInc's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.20) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pliant TherapeuticsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pliant TherapeuticsInc Backtested Returns
Pliant TherapeuticsInc maintains Sharpe Ratio (i.e., Efficiency) of -0.14, which implies the firm had a -0.14% return per unit of risk over the last 3 months. Pliant TherapeuticsInc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pliant TherapeuticsInc's Coefficient Of Variation of (723.06), risk adjusted performance of (0.08), and Variance of 9.62 to confirm the risk estimate we provide. The company holds a Beta of 2.17, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pliant TherapeuticsInc will likely underperform. Pliant TherapeuticsInc has an expected return of -0.42%. Please make sure to check Pliant TherapeuticsInc standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Pliant TherapeuticsInc performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.08 |
Very weak reverse predictability
Pliant TherapeuticsInc has very weak reverse predictability. Overlapping area represents the amount of predictability between Pliant TherapeuticsInc time series from 4th of March 2024 to 18th of April 2024 and 18th of April 2024 to 2nd of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pliant TherapeuticsInc price movement. The serial correlation of -0.08 indicates that barely 8.0% of current Pliant TherapeuticsInc price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 1.24 |
Pliant TherapeuticsInc lagged returns against current returns
Autocorrelation, which is Pliant TherapeuticsInc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pliant TherapeuticsInc's stock expected returns. We can calculate the autocorrelation of Pliant TherapeuticsInc returns to help us make a trade decision. For example, suppose you find that Pliant TherapeuticsInc has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pliant TherapeuticsInc regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pliant TherapeuticsInc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pliant TherapeuticsInc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pliant TherapeuticsInc stock over time.
Current vs Lagged Prices |
| Timeline |
Pliant TherapeuticsInc Lagged Returns
When evaluating Pliant TherapeuticsInc's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pliant TherapeuticsInc stock have on its future price. Pliant TherapeuticsInc autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pliant TherapeuticsInc autocorrelation shows the relationship between Pliant TherapeuticsInc stock current value and its past values and can show if there is a momentum factor associated with investing in Pliant TherapeuticsInc.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pliant TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pliant TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pliant Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pliant Therapeuticsinc Stock:Check out Pliant TherapeuticsInc Correlation, Pliant TherapeuticsInc Volatility and Pliant TherapeuticsInc Alpha and Beta module to complement your research on Pliant TherapeuticsInc. For more information on how to buy Pliant Stock please use our How to Invest in Pliant TherapeuticsInc guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Pliant Stock analysis
When running Pliant TherapeuticsInc's price analysis, check to measure Pliant TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant TherapeuticsInc is operating at the current time. Most of Pliant TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Pliant TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant TherapeuticsInc's price. Additionally, you may evaluate how the addition of Pliant TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world |
Pliant TherapeuticsInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.